25 XP   0   0   10

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Wolwo Bio-Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
84.6%

What is your share worth?

Current worth
¥4.33
Expected worth in 1 year
¥4.82
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.69
Return On Investment
3.0%

For what price can you sell your share?

Current Price per Share
¥22.73
Expected price per share
¥18.44 - ¥26.68
How sure are you?
50%

1. Valuation of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥22.73

Intrinsic Value Per Share

¥1.78 - ¥2.00

Total Value Per Share

¥6.11 - ¥6.33

2. Growth of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$313.8m$261.5m$33.8m11.5%

How much money is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$10m$13.5m-$3.4m-33.9%
Net Profit Margin32.6%43.5%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is ¥22.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Wolwo Bio-Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.33. Based on the TTM, the Book Value Change Per Share is ¥0.12 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.1%0.020.1%0.030.1%0.020.1%0.020.1%
Usd Book Value Change Per Share0.030.1%0.020.1%0.020.1%0.020.1%0.020.1%
Usd Dividend Per Share0.030.1%0.010.0%0.020.1%0.020.1%0.010.1%
Usd Total Gains Per Share0.060.3%0.020.1%0.040.2%0.030.2%0.030.1%
Usd Price Per Share4.12-5.75-6.81-6.84-6.26-
Price to Earnings Ratio32.04-127.84-73.39-102.29-132.14-
Price-to-Total Gains Ratio69.91-618.04-192.50-317.29-362.31-
Price to Book Ratio6.87-10.30-13.69-16.50-25.22-
Price-to-Total Gains Ratio69.91-618.04-192.50-317.29-362.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.145832
Number of shares317
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share0.020.02
Usd Total Gains Per Share0.020.03
Gains per Quarter (317 shares)7.5910.82
Gains per Year (317 shares)30.3843.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
192220212233
2184350424476
32665806466119
435861108588162
544108140106110205
653129170127132248
762151200149154291
870173230170176334
979194260191198377
1088216290212220420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%39.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%31.08.00.079.5%31.08.00.079.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%18.00.02.090.0%33.00.06.084.6%33.00.06.084.6%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%39.00.00.0100.0%

Fundamentals of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.

Fundamental data was last updated by Penke on 2024-03-26 00:12:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Wolwo Bio-Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 42.3% means that ¥0.42 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 42.3%. The company is making a huge profit. +2
  • The TTM is 32.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ42.3%TTM32.6%+9.7%
TTM32.6%YOY43.5%-10.9%
TTM32.6%5Y41.3%-8.7%
5Y41.3%10Y42.7%-1.4%
1.1.2. Return on Assets

Shows how efficient Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 4.8% Return on Assets means that Zhejiang Wolwo Bio-Pharmaceutical Co Ltd generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 4.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.8%TTM3.0%+1.8%
TTM3.0%YOY4.8%-1.8%
TTM3.0%5Y4.6%-1.6%
5Y4.6%10Y5.1%-0.4%
1.1.3. Return on Equity

Shows how efficient Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 5.7% Return on Equity means Zhejiang Wolwo Bio-Pharmaceutical Co Ltd generated ¥0.06 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 5.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.7%TTM3.5%+2.2%
TTM3.5%YOY5.3%-1.8%
TTM3.5%5Y5.1%-1.6%
5Y5.1%10Y5.5%-0.3%

1.2. Operating Efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Wolwo Bio-Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM30.1%-30.1%
TTM30.1%YOY42.0%-11.9%
TTM30.1%5Y41.5%-11.4%
5Y41.5%10Y24.0%+17.4%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.56 means that the operating costs are ¥0.56 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.563. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.670. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.563TTM0.670-0.107
TTM0.670YOY0.578+0.091
TTM0.6705Y0.599+0.070
5Y0.59910Y0.352+0.247

1.3. Liquidity of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 9.31 means the company has ¥9.31 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 9.308. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.639. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.308TTM11.639-2.330
TTM11.639YOY16.454-4.815
TTM11.6395Y17.002-5.363
5Y17.00210Y9.544+7.458
1.3.2. Quick Ratio

Measures if Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 2.01 means the company can pay off ¥2.01 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 2.005. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.513. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.005TTM3.513-1.508
TTM3.513YOY6.943-3.429
TTM3.5135Y5.418-1.904
5Y5.41810Y5.121+0.296

1.4. Solvency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.10 means that Zhejiang Wolwo Bio-Pharmaceutical Co Ltd assets are financed with 9.7% credit (debt) and the remaining percentage (100% - 9.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.097. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.092. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.097TTM0.092+0.005
TTM0.092YOY0.058+0.033
TTM0.0925Y0.060+0.031
5Y0.06010Y0.053+0.007
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 11.3% means that company has ¥0.11 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The MRQ is 0.113. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.106. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.106+0.007
TTM0.106YOY0.064+0.042
TTM0.1065Y0.068+0.038
5Y0.06810Y0.058+0.010

2. Market Valuation of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Wolwo Bio-Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of 32.04 means the investor is paying ¥32.04 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The EOD is 24.479. Based on the earnings, the company is fair priced.
  • The MRQ is 32.039. Based on the earnings, the company is overpriced. -1
  • The TTM is 127.839. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD24.479MRQ32.039-7.560
MRQ32.039TTM127.839-95.800
TTM127.839YOY73.386+54.454
TTM127.8395Y102.289+25.551
5Y102.28910Y132.141-29.852
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The EOD is 77.287. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 101.157. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 940.836. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD77.287MRQ101.157-23.870
MRQ101.157TTM940.836-839.679
TTM940.836YOY-271.303+1,212.138
TTM940.8365Y266.201+674.634
5Y266.20110Y214.873+51.328
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 6.87 means the investor is paying ¥6.87 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd:

  • The EOD is 5.248. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.868. Based on the equity, the company is overpriced. -1
  • The TTM is 10.298. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.248MRQ6.868-1.621
MRQ6.868TTM10.298-3.430
TTM10.298YOY13.688-3.390
TTM10.2985Y16.500-6.202
5Y16.50010Y25.222-8.722
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2250.123+83%0.134+68%0.126+80%0.111+103%
Book Value Per Share--4.3314.077+6%3.610+20%3.133+38%2.201+97%
Current Ratio--9.30811.639-20%16.454-43%17.002-45%9.544-2%
Debt To Asset Ratio--0.0970.092+6%0.058+65%0.060+60%0.053+83%
Debt To Equity Ratio--0.1130.106+7%0.064+76%0.068+67%0.058+96%
Dividend Per Share--0.2000.050+299%0.151+33%0.121+65%0.097+106%
Eps--0.2320.139+67%0.187+24%0.151+54%0.113+106%
Free Cash Flow Per Share--0.0740.061+20%0.096-24%0.080-8%0.088-16%
Free Cash Flow To Equity Per Share--0.0740.108-32%0.045+65%0.071+3%0.121-39%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.996--------
Intrinsic Value_10Y_min--1.780--------
Intrinsic Value_1Y_max--0.318--------
Intrinsic Value_1Y_min--0.312--------
Intrinsic Value_3Y_max--0.865--------
Intrinsic Value_3Y_min--0.828--------
Intrinsic Value_5Y_max--1.305--------
Intrinsic Value_5Y_min--1.219--------
Market Cap11901064320.000-31%15576624000.00021739207680.000-28%25768186560.000-40%25875925032.000-40%23666902339.077-34%
Net Profit Margin--0.4230.326+30%0.435-3%0.413+2%0.427-1%
Operating Margin---0.301-100%0.420-100%0.415-100%0.240-100%
Operating Ratio--0.5630.670-16%0.578-3%0.599-6%0.352+60%
Pb Ratio5.248-31%6.86810.298-33%13.688-50%16.500-58%25.222-73%
Pe Ratio24.479-31%32.039127.839-75%73.386-56%102.289-69%132.141-76%
Price Per Share22.730-31%29.75041.520-28%49.215-40%49.420-40%45.201-34%
Price To Free Cash Flow Ratio77.287-31%101.157940.836-89%-271.303+368%266.201-62%214.873-53%
Price To Total Gains Ratio53.413-31%69.909618.035-89%192.503-64%317.294-78%362.308-81%
Quick Ratio--2.0053.513-43%6.943-71%5.418-63%5.121-61%
Return On Assets--0.0480.030+59%0.048+1%0.046+5%0.051-4%
Return On Equity--0.0570.035+61%0.053+8%0.051+10%0.055+4%
Total Gains Per Share--0.4260.173+146%0.285+50%0.247+73%0.208+105%
Usd Book Value--313875095.689295444488.521+6%261579700.591+20%227039297.710+38%159490431.614+97%
Usd Book Value Change Per Share--0.0310.017+83%0.019+68%0.017+80%0.015+103%
Usd Book Value Per Share--0.5990.564+6%0.500+20%0.434+38%0.305+97%
Usd Dividend Per Share--0.0280.007+299%0.021+33%0.017+65%0.013+106%
Usd Eps--0.0320.019+67%0.026+24%0.021+54%0.016+106%
Usd Free Cash Flow--5327883.8774451968.852+20%6971838.421-24%5792270.980-8%6349883.605-16%
Usd Free Cash Flow Per Share--0.0100.009+20%0.013-24%0.011-8%0.012-16%
Usd Free Cash Flow To Equity Per Share--0.0100.015-32%0.006+65%0.010+3%0.017-39%
Usd Market Cap1647107301.888-31%2155804761.6003008706342.912-28%3566317019.904-40%3581228024.429-40%3275499283.728-34%
Usd Price Per Share3.146-31%4.1175.746-28%6.811-40%6.840-40%6.256-34%
Usd Profit--16821592.56110092996.921+67%13515265.367+24%10914236.198+54%8159283.867+106%
Usd Revenue--39789390.54630089073.991+32%30730016.517+29%26075326.088+53%19014328.451+109%
Usd Total Gains Per Share--0.0590.024+146%0.039+50%0.034+73%0.029+105%
 EOD+4 -4MRQTTM+24 -11YOY+21 -145Y+23 -1210Y+18 -17

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.479
Price to Book Ratio (EOD)Between0-15.248
Net Profit Margin (MRQ)Greater than00.423
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.005
Current Ratio (MRQ)Greater than19.308
Debt to Asset Ratio (MRQ)Less than10.097
Debt to Equity Ratio (MRQ)Less than10.113
Return on Equity (MRQ)Greater than0.150.057
Return on Assets (MRQ)Greater than0.050.048
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.575
Ma 20Greater thanMa 5024.787
Ma 50Greater thanMa 10024.307
Ma 100Greater thanMa 20026.459
OpenGreater thanClose22.780
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,510,658
Total Liabilities242,774
Total Stockholder Equity2,144,980
 As reported
Total Liabilities 242,774
Total Stockholder Equity+ 2,144,980
Total Assets = 2,510,658

Assets

Total Assets2,510,658
Total Current Assets1,564,065
Long-term Assets946,593
Total Current Assets
Cash And Cash Equivalents 1,067,376
Short-term Investments 116,481
Net Receivables 220,457
Inventory 55,390
Other Current Assets 15,718
Total Current Assets  (as reported)1,564,065
Total Current Assets  (calculated)1,475,423
+/- 88,642
Long-term Assets
Property Plant Equipment 659,044
Intangible Assets 189,029
Long-term Assets  (as reported)946,593
Long-term Assets  (calculated)848,073
+/- 98,520

Liabilities & Shareholders' Equity

Total Current Liabilities168,029
Long-term Liabilities74,745
Total Stockholder Equity2,144,980
Total Current Liabilities
Short Long Term Debt 14,667
Accounts payable 7,730
Total Current Liabilities  (as reported)168,029
Total Current Liabilities  (calculated)22,396
+/- 145,632
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt14,971
Long-term Liabilities Other 28,219
Long-term Liabilities  (as reported)74,745
Long-term Liabilities  (calculated)43,190
+/- 31,556
Total Stockholder Equity
Retained Earnings 1,258,052
Total Stockholder Equity (as reported)2,144,980
Total Stockholder Equity (calculated)1,258,052
+/- 886,928
Other
Capital Stock523,584
Common Stock Shares Outstanding 523,584
Net Invested Capital 2,159,646
Net Working Capital 1,396,036
Property Plant and Equipment Gross 659,044



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-06-302012-12-312011-12-312010-12-31
> Total Assets 
110,524
147,188
191,113
223,518
263,955
475,857
466,964
508,330
531,307
505,319
534,746
577,755
611,488
639,603
607,984
663,103
696,895
728,836
728,568
805,913
848,311
903,275
891,042
1,001,924
1,057,893
1,248,240
1,238,408
1,374,187
1,428,211
1,451,911
1,425,314
1,562,152
1,604,756
1,690,192
1,672,994
1,853,615
1,931,961
1,972,265
1,979,306
2,146,643
2,197,875
2,257,726
2,440,683
2,510,658
2,510,6582,440,6832,257,7262,197,8752,146,6431,979,3061,972,2651,931,9611,853,6151,672,9941,690,1921,604,7561,562,1521,425,3141,451,9111,428,2111,374,1871,238,4081,248,2401,057,8931,001,924891,042903,275848,311805,913728,568728,836696,895663,103607,984639,603611,488577,755534,746505,319531,307508,330466,964475,857263,955223,518191,113147,188110,524
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
684,961
762,493
781,658
958,463
929,049
1,027,822
1,050,003
1,059,605
1,025,466
1,146,895
1,170,938
1,233,322
1,191,838
1,285,529
1,341,511
1,360,298
1,362,264
1,450,375
1,477,133
1,464,063
1,589,807
1,564,065
1,564,0651,589,8071,464,0631,477,1331,450,3751,362,2641,360,2981,341,5111,285,5291,191,8381,233,3221,170,9381,146,8951,025,4661,059,6051,050,0031,027,822929,049958,463781,658762,493684,9610000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
369,140
428,844
460,043
730,414
673,870
625,860
750,771
802,447
776,998
622,946
583,680
742,703
690,792
617,842
649,994
722,402
748,289
782,487
840,688
920,415
1,182,358
1,067,376
1,067,3761,182,358920,415840,688782,487748,289722,402649,994617,842690,792742,703583,680622,946776,998802,447750,771625,860673,870730,414460,043428,844369,1400000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130,000
0
116,000
16,118
32,227
104,450
41,371
37,377
17,042
218,026
307,034
228,163
211,015
312,470
370,934
327,775
308,609
298,970
295,054
233,068
91,842
116,481
116,48191,842233,068295,054298,970308,609327,775370,934312,470211,015228,163307,034218,02617,04237,37741,371104,45032,22716,118116,0000130,0000000000000000000000000
       Net Receivables 
26,637
48,189
63,991
66,923
77,794
81,848
84,535
105,956
98,904
92,255
90,757
112,243
102,011
97,117
96,319
126,698
116,237
113,121
117,798
148,031
145,002
143,569
161,801
204,847
170,404
125,675
134,128
197,720
206,281
163,080
174,888
249,771
215,348
193,347
215,864
283,871
249,255
238,083
238,607
308,611
274,123
235,967
238,809
220,457
220,457238,809235,967274,123308,611238,607238,083249,255283,871215,864193,347215,348249,771174,888163,080206,281197,720134,128125,675170,404204,847161,801143,569145,002148,031117,798113,121116,237126,69896,31997,117102,011112,24390,75792,25598,904105,95684,53581,84877,79466,92363,99148,18926,637
       Other Current Assets 
281
179
1,766
3,761
5,987
1,086
365
60,405
627
760
713
72
1,306
1,151
1,729
2,878
2,464
215,663
2,594
280,671
5,854
275,647
6,654
114,218
11,738
4,747
6,788
9,437
14,761
17,419
17,379
19,259
16,545
19,176
22,970
19,900
17,576
23,550
16,768
13,018
18,857
24,009
23,655
15,718
15,71823,65524,00918,85713,01816,76823,55017,57619,90022,97019,17616,54519,25917,37917,41914,7619,4376,7884,74711,738114,2186,654275,6475,854280,6712,594215,6632,4642,8781,7291,1511,3067271376062760,4053651,0865,9873,7611,766179281
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
289,777
309,359
346,366
378,207
392,306
399,848
415,257
433,817
456,870
481,156
568,086
590,450
611,968
617,042
696,269
720,743
793,663
850,876
946,593
946,593850,876793,663720,743696,269617,042611,968590,450568,086481,156456,870433,817415,257399,848392,306378,207346,366309,359289,7770000000000000000000000000
       Property Plant Equipment 
43,728
41,598
43,600
46,524
53,179
50,336
52,192
52,570
60,282
63,978
70,054
80,067
96,971
101,643
102,598
104,549
118,530
118,752
117,687
117,325
123,564
125,118
131,779
132,915
137,681
146,441
159,169
175,574
197,633
207,395
213,128
225,051
240,162
262,065
265,586
280,390
301,618
322,956
329,308
373,534
444,605
516,011
574,790
659,044
659,044574,790516,011444,605373,534329,308322,956301,618280,390265,586262,065240,162225,051213,128207,395197,633175,574159,169146,441137,681132,915131,779125,118123,564117,325117,687118,752118,530104,549102,598101,64396,97180,06770,05463,97860,28252,57052,19250,33653,17946,52443,60041,59843,728
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,000
13,000
13,000
13,000
13,000
13,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000013,00013,00013,00013,00013,00013,0000000000000000000000000
       Intangible Assets 
13,174
14,582
16,197
17,946
19,404
4,718
5,024
4,976
4,929
4,881
4,833
4,818
4,776
4,715
4,787
4,754
5,153
5,070
4,988
4,906
5,049
4,956
4,862
31,229
50,120
128,014
112,560
152,279
160,939
162,967
164,978
167,929
170,422
171,178
172,558
173,430
176,350
196,982
196,747
232,192
189,497
190,547
188,252
189,029
189,029188,252190,547189,497232,192196,747196,982176,350173,430172,558171,178170,422167,929164,978162,967160,939152,279112,560128,01450,12031,2294,8624,9565,0494,9064,9885,0705,1534,7544,7874,7154,7764,8184,8334,8814,9294,9765,0244,71819,40417,94616,19714,58213,174
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
289,777
309,359
346,366
378,207
392,306
0
225,051
0
0
19,627
19,627
19,627
0
0
0
0
0
0
0
000000019,62719,62719,62700225,0510392,306378,207346,366309,359289,7770000000000000000000000000
> Total Liabilities 
20,080
19,580
9,733
10,627
12,035
18,208
13,624
19,234
17,753
16,082
18,339
21,400
28,574
28,215
27,494
34,161
41,318
35,054
34,671
42,265
47,053
50,075
50,481
49,252
62,472
50,852
50,518
72,157
76,253
59,717
63,530
81,068
76,608
94,316
86,528
123,670
135,356
86,694
111,686
136,332
170,760
163,683
290,867
242,774
242,774290,867163,683170,760136,332111,68686,694135,356123,67086,52894,31676,60881,06863,53059,71776,25372,15750,51850,85262,47249,25250,48150,07547,05342,26534,67135,05441,31834,16127,49428,21528,57421,40018,33916,08217,75319,23413,62418,20812,03510,6279,73319,58020,080
   > Total Current Liabilities 
16,539
16,924
7,963
9,299
12,035
18,208
13,624
16,363
16,203
14,532
14,393
17,454
24,629
24,270
23,549
29,308
36,465
30,201
29,818
37,412
42,200
45,222
45,628
44,398
57,619
45,980
45,636
60,985
60,030
43,494
47,395
64,786
55,420
64,949
58,385
89,793
107,997
59,590
86,090
98,381
102,751
93,924
218,289
168,029
168,029218,28993,924102,75198,38186,09059,590107,99789,79358,38564,94955,42064,78647,39543,49460,03060,98545,63645,98057,61944,39845,62845,22242,20037,41229,81830,20136,46529,30823,54924,27024,62917,45414,39314,53216,20316,36313,62418,20812,0359,2997,96316,92416,539
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
27,333
14,667
14,66727,33320,00000000000000000000000000000000000000000000
       Accounts payable 
737
625
630
1,186
597
1,043
1,419
783
999
961
1,299
1,139
598
1,145
1,179
1,082
1,027
947
1,080
1,006
1,380
877
2,533
2,626
3,447
4,846
4,227
3,952
8,684
4,617
6,218
6,228
5,663
5,668
5,922
5,086
5,085
5,133
8,507
8,619
7,683
5,374
6,462
7,730
7,7306,4625,3747,6838,6198,5075,1335,0855,0865,9225,6685,6636,2286,2184,6178,6843,9524,2274,8463,4472,6262,5338771,3801,0061,0809471,0271,0821,1791,1455981,1391,2999619997831,4191,0435971,186630625737
       Other Current Liabilities 
5,802
6,299
7,333
8,113
11,438
17,166
12,205
15,580
15,204
13,571
13,094
16,315
24,030
23,125
22,371
28,226
35,438
29,254
28,738
36,406
40,819
44,344
33,934
31,601
39,708
31,986
29,736
42,172
31,607
28,349
27,189
41,701
26,606
43,360
29,138
64,355
61,514
37,213
51,657
58,901
64,637
49,449
157,412
0
0157,41249,44964,63758,90151,65737,21361,51464,35529,13843,36026,60641,70127,18928,34931,60742,17229,73631,98639,70831,60133,93444,34440,81936,40628,73829,25435,43828,22622,37123,12524,03016,31513,09413,57115,20415,58012,20517,16611,4388,1137,3336,2995,802
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,872
4,882
11,173
16,223
16,223
16,135
16,282
21,188
29,366
28,143
33,876
27,360
27,104
25,596
37,951
68,009
69,759
72,578
74,745
74,74572,57869,75968,00937,95125,59627,10427,36033,87628,14329,36621,18816,28216,13516,22316,22311,1734,8824,8720000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,915
2,833
1,759
1,947
1,483
502
12,792
12,283
14,144
12,609
14,971
14,97112,60914,14412,28312,7925021,4831,9471,7592,8333,915000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,219
28,219
28,219
28,219
28,21928,21928,21928,2190000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,543
60,047
73,551
79,097
86,863
88,891
98,485
103,583
106,312
110,040
113,890
74,828
77,894
80,429
86,045
88,567
90,502
93,278
53,196
57,581
26,618
0
026,61857,58153,19693,27890,50288,56786,04580,42977,89474,828113,890110,040106,312103,58398,48588,89186,86379,09773,55160,04754,5430000000000000000000000
> Total Stockholder Equity
90,417
127,580
181,357
212,881
251,910
457,646
453,336
489,093
513,550
489,237
516,408
556,355
582,914
611,388
580,490
628,942
655,577
693,782
693,896
763,648
801,258
853,199
840,561
925,973
969,517
1,111,413
1,103,042
1,219,153
1,270,996
1,312,371
1,283,812
1,405,875
1,455,909
1,526,364
1,519,448
1,666,005
1,736,068
1,827,801
1,811,922
1,958,073
1,979,627
2,050,013
2,023,438
2,144,980
2,144,9802,023,4382,050,0131,979,6271,958,0731,811,9221,827,8011,736,0681,666,0051,519,4481,526,3641,455,9091,405,8751,283,8121,312,3711,270,9961,219,1531,103,0421,111,413969,517925,973840,561853,199801,258763,648693,896693,782655,577628,942580,490611,388582,914556,355516,408489,237513,550489,093453,336457,646251,910212,881181,357127,58090,417
   Common Stock
86,954
90,000
90,000
90,000
90,000
101,000
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
161,600
290,880
290,880
290,880
290,880
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
523,584
0
0523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584523,584290,880290,880290,880290,880161,600161,600161,600161,600161,600161,600161,600161,600161,600161,600161,600161,600161,600161,600161,600161,600101,00090,00090,00090,00090,00086,954
   Retained Earnings 
3,084
33,538
81,931
113,461
145,436
174,952
110,042
145,799
170,258
145,946
173,111
213,046
239,598
268,074
237,167
285,617
312,239
350,446
350,569
420,327
457,943
509,897
497,243
582,641
626,187
598,700
357,617
473,721
619,059
660,428
631,869
753,945
803,261
873,716
866,805
1,014,221
1,084,289
1,176,024
1,160,130
1,306,265
1,327,822
1,398,214
1,371,624
1,258,052
1,258,0521,371,6241,398,2141,327,8221,306,2651,160,1301,176,0241,084,2891,014,221866,805873,716803,261753,945631,869660,428619,059473,721357,617598,700626,187582,641497,243509,897457,943420,327350,569350,446312,239285,617237,167268,074239,598213,046173,111145,946170,258145,799110,042174,952145,436113,46181,93133,5383,084
   Capital Surplus 00000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
22
21
14
22
30
158
165
165
152
869
870
866
6
1
-2
13
30
27
21
36
0
03621273013-216866870869152165165158302214212280000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue869,626
Cost of Revenue-41,627
Gross Profit827,999827,999
 
Operating Income (+$)
Gross Profit827,999
Operating Expense-530,580
Operating Income339,046297,419
 
Operating Expense (+$)
Research Development108,195
Selling General Administrative337,924
Selling And Marketing Expenses-
Operating Expense530,580446,119
 
Net Interest Income (+$)
Interest Income19,768
Interest Expense-1,111
Other Finance Cost-9,898
Net Interest Income28,556
 
Pretax Income (+$)
Operating Income339,046
Net Interest Income28,556
Other Non-Operating Income Expenses-
Income Before Tax (EBT)321,693339,046
EBIT - interestExpense = -1,111
291,705
292,816
Interest Expense1,111
Earnings Before Interest and Taxes (EBIT)-322,804
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax321,693
Tax Provision-45,104
Net Income From Continuing Ops276,589276,589
Net Income291,705
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--28,556
 

Technical Analysis of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The general trend of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.17 < 26.15 < 26.68.

The bearish price targets are: 18.44.

Tweet this
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current macd is -0.513306.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Wolwo Bio-Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Wolwo Bio-Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current adx is 19.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Wolwo Bio-Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current sar is 25.95.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current rsi is 34.57. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Wolwo Bio-Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current cci is -153.82756955.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current cmo is -47.75956467.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current willr is -91.0041841.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current atr is 0.92439451.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current obv is -55,404,301.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. The current mfi is 36.25.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.575
Ma 20Greater thanMa 5024.787
Ma 50Greater thanMa 10024.307
Ma 100Greater thanMa 20026.459
OpenGreater thanClose22.780
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Wolwo Bio-Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Wolwo Bio-Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Wolwo Bio-Pharmaceutical Co Ltd in your mailbox!